Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
The Staying Inside Guide: Jazz Performances That Stand the Test of Time
08:19pm, Tuesday, 07'th Apr 2020
From the 1940s, ’50s and ’60s, they capture not only the sounds and sights of jazz, but—more important—its feeling and deep inner essence.
Grading The 2019-20 Utah Jazz: The Reserves
06:56pm, Tuesday, 07'th Apr 2020
With a strong likelihood the 2019-20 Utah Jazz season is over, we broke down and graded each of their reserves over the course of the year.
How 3 Philly-area biopharmaceutical firms are working through coronavirus challenges
10:40am, Tuesday, 07'th Apr 2020
Philadelphia-area life science companies say they are continuing their drug development efforts, but they expect to encounter some delays because of workplace restrictions during the coronavirus pande
Immunomedics nabs new CEO as data revives hopes its troubled cancer drug can make the finish line
02:56pm, Monday, 06'th Apr 2020
Former Ipsen and Novartis exec Harout Semerjian has been tapped as the latest chief executive of troubled Immunomedics.
Fly Intel: Top five analyst initiations JAZZ;CLAR;IMRA;IDYA;SLAB
02:42pm, Monday, 06'th Apr 2020
Fly Intel: Top five analyst initiations JAZZ CLAR IMRA IDYA SLAB
Jazz Pharmaceuticals initiated with a Buy at Jefferies JAZZ
12:07pm, Monday, 06'th Apr 2020
Jazz Pharmaceuticals initiated with a Buy at Jefferies Jefferies JAZZ
Norges Bank Makes New $99.89 Million Investment in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
11:16am, Monday, 06'th Apr 2020
Norges Bank bought a new position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. Th
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Invests $94,000 in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
10:06am, Monday, 06'th Apr 2020
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) during the fourth quarter, according to its most recent 13F filing
Morgan Stanley Lowers Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $109.00
09:26am, Monday, 06'th Apr 2020
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price objective cut by Morgan Stanley from $147.00 to $109.00 in a research note issued to investors on Thursday, AnalystRatings.com reports. They currently
Jefferies Initiates Coverage On Jazz Pharmaceuticals with Buy Rating, Announces Price Target to $149
12:00am, Monday, 06'th Apr 2020Equities Analysts Set Expectations for Jazz Pharmaceuticals PLC's FY2020 Earnings (NASDAQ:JAZZ)
08:22am, Saturday, 04'th Apr 2020
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – SVB Leerink dropped their FY2020 earnings per share estimates for shares of Jazz Pharmaceuticals in a note issued to investors on Tuesday, March 31st. SVB Le
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abeona Therapeutics (ABEO), Teva Pharmaceutical Industries (TEVA) and
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abeona Therapeutics (
ABEO
–
Research Report
), Teva Pharmaceutical Industries (
TEVA
–
Research Report
) and Capr
Analysts Are Bullish on These Healthcare Stocks: OrthoPediatrics (KIDS), Horizon Therapeutics (HZNP)
05:26pm, Thursday, 02'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on OrthoPediatrics (KIDS), Horizon Therapeutics (HZNP) and
Morgan Stanley Maintains Their Hold Rating on Jazz Pharmaceuticals (JAZZ)
05:07pm, Thursday, 02'nd Apr 2020
In a report released today, David Risinger from Morgan Stanley maintained a Hold rating on Jazz Pharmaceuticals (JAZZ), with a price target of $109.00.
